Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Active-control, Multicenter, Randomized, Open-label, Safety And Efficacy Study Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary Embolism In Japanese

NCT01780987 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01780987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01780987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Active-control, Multicenter, Randomized, Open-label, Safety And Efficacy Study Evaluating The Use Of Apixaban In The Treatment Of Symptomatic Deep Vein Thrombosis And Pulmonary Embolism In Japanese
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
September 30, 2014
Enrollment
80 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

deep vein thrombosis, pulmonary embolism